Kevin Fitzgerald - 06 Oct 2021 Form 3 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Kevin Joseph Fitzgerald by PoA
Issuer symbol
OVID
Transactions as of
06 Oct 2021
Transactions value $
$0
Form type
3
Filing time
07 Oct 2021, 16:27:29 UTC
Next filing
04 Feb 2022

No securities are beneficially owned.